BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8299657)

  • 1. Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography.
    Hoekstra OS; van Lingen A; Ossenkoppele GJ; Golding R; Teule GJ
    Eur J Nucl Med; 1993 Dec; 20(12):1214-7. PubMed ID: 8299657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
    Zijlstra JM; Hoekstra OS; Raijmakers PG; Comans EF; van der Hoeven JJ; Teule GJ; Jonkhoff AR; v Tinteren H; Lammertsma AA; Huijgens PC
    Br J Haematol; 2003 Nov; 123(3):454-62. PubMed ID: 14617005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas.
    Dimitrakopoulou-Strauss A; Strauss LG; Goldschmidt H; Lorenz WJ; Maier-Borst W; van Kaick G
    Eur J Nucl Med; 1995 May; 22(5):434-42. PubMed ID: 7641752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
    Herrmann K; Wieder HA; Buck AK; Schöffel M; Krause BJ; Fend F; Schuster T; Meyer zum Büschenfelde C; Wester HJ; Duyster J; Peschel C; Schwaiger M; Dechow T
    Clin Cancer Res; 2007 Jun; 13(12):3552-8. PubMed ID: 17575218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.
    Adams HJA; Kwee TC
    Ann Hematol; 2018 Apr; 97(4):719-720. PubMed ID: 29222579
    [No Abstract]   [Full Text] [Related]  

  • 6. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
    Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
    Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
    Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
    Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of R-CHOP chemotherapy on liver and mediastinal blood pool (18)F-FDG standardized uptake values in patients with non-Hodgkin's lymphoma.
    Kaya B; Dostbil Z; Ismailoglu M; Tasdemir B; Sahin O
    Clin Imaging; 2015; 39(4):632-5. PubMed ID: 25709112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Resulting Changes in Volumes of High-
    Huang YM; Hsieh CH; Wang SY; Tsao CH; Lee JC; Chen YJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOP versus m-BACOD in non-Hodgkin's lymphoma.
    Hryniuk W
    N Engl J Med; 1993 Feb; 328(8):581. PubMed ID: 7678920
    [No Abstract]   [Full Text] [Related]  

  • 11. Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
    Zinzani PL; Gandolfi L; Broccoli A; Argnani L; Fanti S; Pellegrini C; Stefoni V; Derenzini E; Quirini F; Baccarani M
    Cancer; 2011 Mar; 117(5):1010-8. PubMed ID: 20960498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary malignant non-Hodgkin's lymphoma of the heart].
    Iwuagwu OC; Kober R
    Rofo; 2002 Dec; 174(12):1578-9. PubMed ID: 12471533
    [No Abstract]   [Full Text] [Related]  

  • 13. Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography.
    Matthies A; Schuster SJ; Alavi A
    Clin Lymphoma; 2001 Mar; 1(4):303-6; discussion 307. PubMed ID: 11707846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
    Provencio M; Fayad LE
    Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of PET-18FDG imaging in the clinical evaluation of head and neck lymphoma.
    Walsh RM; Wong WL; Chevretton EB; Beaney RP
    Clin Oncol (R Coll Radiol); 1996; 8(1):51-4. PubMed ID: 8688363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of MACOP B polychemotherapy for malignant non-Hodgkin's lymphomas in AIDS infected patients].
    Taillan B; Ferrari E; Garnier G; Fuzibet JG; Vinti H; Dujardin P
    Presse Med; 1992 Feb; 21(6):269. PubMed ID: 1372976
    [No Abstract]   [Full Text] [Related]  

  • 17. 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
    Tempescul A; Querellou S; Ianotto JC; Boisramé S; Valette G; Berthou C
    Ann Hematol; 2010 Jun; 89(6):635-7. PubMed ID: 19844711
    [No Abstract]   [Full Text] [Related]  

  • 18. Change of cerebral glucose metabolism by antineoplastic drug.
    Okada J; Yoshikawa K; Imazeki K; Uno K; Minoshima S; Itami J; Maruno H; Kuyama J; Arimizu N
    Am J Physiol Imaging; 1991; 6(4):162-6. PubMed ID: 1726307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
    Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.
    Hoekstra OS; Ossenkoppele GJ; Golding R; van Lingen A; Visser GW; Teule GJ; Huijgens PC
    J Nucl Med; 1993 Oct; 34(10):1706-10. PubMed ID: 8410287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.